Theodore Evan

CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth

David J. Barry, A. Snijders, A. Behrens, 2019, Nature Cell Biology.

The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma

Axel Behrens, V. M. Wang, Theodore Evan, 2022, Oncogene.

GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

A. Sadanandam, G. Koifman, Y. Zen, 2022, Nature.

Cohesin-dependent regulation of gene expression during differentiation is lost in Cohesin-mutated myeloid malignancies.

Cameron S. Osborne, Nicola K. Wilson, P. Campbell, 2019, Blood.

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

G. Koifman, A. Snijders, A. Behrens, 2022, Nature Communications.